Portal de investigación
CONTRATOS MIGUEL SERVET
Datos básicos
- Protocolo:
- CP21/00025
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
- Año de incio:
- 2022
- Año de finalización:
- 2026
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
Lavandula viridis L'Her. Essential Oil Inhibits the Inflammatory Response in Macrophages Through Blockade of NF-KB Signaling Cascade
Zuzarte, M; (...); Cruz, MT
Article. 10.3389/fphar.2021.695911. 2022
Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
Francisco, Vera; (...); Gualillo, Oreste
Article. 10.3390/biology11081237. 2022
Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells
Francisco, Vera; (...); Gualillo, Oreste
Article. 10.1016/j.spinee.2023.06.005. 2023
Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?
Article. 10.1016/j.phrs.2024.107058. 2024
